IDEX Biometrics issues a Convertible Bond to prepare for commercial ramp-up

BY GlobeNewswire | CORPORATE | 11/07/23 02:10 AM EST

Oslo, Norway ? 7 November 2023 ? IDEX Biometrics (IDXAF) (Idex or the Company) has entered into a non-binding term sheet with a new institutional investor group to issue a senior convertible bond for up to 100 million NOK. The convertible bond structure is subject to approval of the formal agreements and shareholder approval.

The convertible bond will be issued at a price of 92% of the principal amount, and will be amortized over 3,5 years through instalment every 2 months over the period. The instalment periods may be altered during the amortizing period. Idex may choose repayment between equity and cash for each instalment. Interest rate is 6% pa. Conversion price will be at a premium to the stock price at closing of the final agreements and any repayments by issuance of shares will be at a discount to market price at each instalment.?

To approve the convertible bond, IDEX Biometrics (IDXAF) will call for an extraordinary meeting (EGM) on or about 30 November 2023 at 10:00 hours CET, held as an online meeting. The notice of the EGM with attendance forms will be sent to the shareholders soonest. The notice of the EGM will also be disclosed in a notice to the market.

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act


Image: Primary Logo


In general the bond market is volatile, and fixed income securities carry interest rate risk. (As interest rates rise, bond prices usually fall, and vice versa. This effect is usually more pronounced for longer-term securities.) Fixed income securities also carry inflation risk and credit and default risks for both issuers and counterparties. Unlike individual bonds, most bond funds do not have a maturity date, so avoiding losses caused by price volatility by holding them until maturity is not possible.

Lower-quality debt securities generally offer higher yields, but also involve greater risk of default or price changes due to potential changes in the credit quality of the issuer. Any fixed income security sold or redeemed prior to maturity may be subject to loss.

Before investing, consider the funds' investment objectives, risks, charges, and expenses. Contact Fidelity for a prospectus or, if available, a summary prospectus containing this information. Read it carefully.